Institutional Options Data Providers Compared 2026 - Bloomberg, LSEG, OptionMetrics, ORATS

Most vendor comparisons in this space line up feature checkboxes and declare a winner. That is useless to an institutional buyer, because the five products below are not substitutes. They differ on a more basic axis: what is stored, who owns the methodology, and whether the consumer is a person or a model.

This page is the matrix. Each vendor has a dedicated deep-dive linked from its section. If you want the decision framework rather than the head-to-head, read the four ways funds actually source options analytics instead.

Full disclosure: I built FlashAlpha, which is one of the five. I have tried to write the other four as their own users would describe them, and every section says where FlashAlpha loses.

The matrix

Pricing, with sources and caveats

Read this table with its caveats attached. Only two of these five publish list prices at all; the rest are quote-based and the figures shown are widely reported reference points as of August 2026, not vendor statements. Anyone presenting a precise number for a quote-only vendor is guessing.

The spread here is close to three orders of magnitude, and that alone should tell you these are not competing offers. A $99 ORATS plan and a $31,980 Bloomberg seat are not on the same axis, and choosing between them on price is choosing between a bicycle and a container ship on the basis of weight.

Bloomberg: the terminal you probably already have

Bloomberg is the most complete financial workstation ever built and the closest thing the industry has to a common language. For discretionary work it is close to unbeatable, and the seat bundles hardware, data, news, chat and support in one predictable number.

Where it fails for systematic options work is not quality but licensing shape. The bundled BLPAPI is metered for a human's incidental pulls: roughly 500,000 data points a day, no more than 3,500 concurrent real-time fields, and a monthly unique-security limit from a proprietary model that Bloomberg does not disclose and you cannot query programmatically. Options research burns unique identifiers extraordinarily fast because every strike and expiry counts separately. Bloomberg does return explicit errors when you hit a ceiling, but there is no counter to read before a job starts, so market-wide chain backfills cannot be planned against their own budget and stop mid-job.

Firm-scale access exists as B-PIPE and Data License, negotiated separately from the seat. Both solve access. Neither ships aggregated dealer positioning.

Buy it when the consumer is a person, or you need cross-asset breadth, news and the counterparty network. Full comparison.

LSEG Workspace: breadth at a lower price point

Workspace replaced Refinitiv Eikon on 30 June 2025. It is a genuine multi-asset workstation with Reuters news, category-leading FX and fixed income depth, decades of macro history through the Datastream lineage, and Excel integration that analysts actually use. Its commercial case against Bloomberg is real.

The thing to understand is the entitlement model: a base platform licence per user, with data entitlements charged separately by asset class and geography. Whether you can pull the options depth a study assumes is therefore a contract question, and the fix for a gap is a procurement cycle rather than a code change. Like Bloomberg, it publishes prices and greeks, not positioning aggregates.

Buy it when you need multi-asset breadth, macro conditioning, or global options coverage, particularly if Bloomberg's price is not justified by your usage. Full comparison.

OptionMetrics IvyDB: the academic standard

IvyDB is the reference options history dataset and what most published options research is built on. IvyDB US covers every US exchange-traded equity and index option end-of-day from January 1996, with standardised implied vols and greeks computed consistently across the whole history. That consistency over thirty years is genuinely hard and genuinely valuable.

Correcting a common error: IvyDB is not end-of-day only. IvyDB US Intraday provides snapshots at 10:00, 14:00 and 15:45 ET from January 2018, and IvyDB Signed Volume provides five- and thirty-minute buy / sell pressure from January 2016. The accurate distinction is that IvyDB samples the day at fixed points while a minute-resolution source traces it.

Where it does not fit is production. It is delivered as bulk data through files, WRDS or Snowflake, and there is no real-time endpoint to point a live strategy at. It stores inputs rather than aggregates, so positioning analytics are yours to build. Note also that the discounted academic licence is refreshed yearly rather than nightly, which is fine for history and useless for anything current.

Buy it when you need pre-2017 history, global coverage, publication-standard provenance, or full methodological control because the positioning model is your edge. Full comparison.

ORATS: backtesting with the work already done

ORATS has been a fixture since 2001 and occupies a useful middle ground: options data with a large library of proprietary indicators, plus a hosted backtester that runs the tests for you rather than handing you a dataset and wishing you luck. EOD history reaches back to 2007 and one-minute data is available from 2020. For a desk that wants to validate a structural options strategy without building a research harness, that packaging is worth a lot.

Where it stops is the same place as the others: it does not publish aggregated dealer positioning, and its intraday history does not reach as far back as its EOD history.

Buy it when you want a hosted backtester and a broad indicator library rather than infrastructure to build on. Full comparison.

FlashAlpha: the computed layer

FlashAlpha publishes the aggregation layer the other four leave to you: per-strike GEX, DEX, VEX and CHEX under a documented dealer-sign convention, gamma flip, call and put walls, max pain, SVI surfaces with raw parameters and arbitrage flags, VRP with z-scores and regime conditioning, and 0DTE analytics. Live and historical share one API contract across 51 mirrored routes, so in the common case the analytic you backtest is the one that runs in production. Parity is close rather than total: earnings, screener and structures are live-only, and three historical response schemas differ in shape from their live counterparts. Coverage is per symbol: the archive holds 75 symbols, 14 of them back to 2017-01-03 (SPY, QQQ, IWM, TSLA, NVDA, MSFT, NFLX, AMZN, GOOG, AMD, INTC, MSTR, T and TLT), most of the rest from 2018, and SPX from 2022. Check /v1/tickers for the exact window before assuming a date is queryable.

Where it loses, and these are real: no pre-2017 history, no non-US options, no fundamentals, news, FX, credit or execution, no per-contract methodological freedom because you adopt my conventions, and it is a small firm rather than an institution, which is genuine vendor risk you should price rather than ignore.

Which one answers your question

The question that actually decides it

Strip away the feature lists and one question does most of the work:

Is the positioning methodology your edge, or an input to it?

If the methodology is the edge, buy inputs and keep control. IvyDB or a raw OPRA-derived feed, and accept the build described in build vs buy. Adopting a vendor's conventions would hand away the thing you are paid for.

If the methodology is an input to an edge that lives elsewhere, buying the computed layer starts research immediately instead of after a multi-quarter build, and the archive is the component that cannot be compressed by hiring.

Sequencing matters more than teams expect. Buying first and building selectively later costs less than building first and discovering the vendor afterwards, because in the second order the build survives on sunk cost rather than merit.

What to demand from any of them

Whichever you shortlist, the evaluation is a methodology evaluation rather than a feature comparison. The full list is in the vendor due-diligence checklist. The four that decide most deals:

• A published, versioned methodology with a limitations section. If the conventions are undocumented you cannot defend the number internally when it disagrees with another source.
• An explicit point-in-time posture. Restatement policy, survivorship, and whether derived statistics are leak-bounded. See why most options backtests are optimistic.
• Visible limits. If you cannot determine your quota programmatically, you cannot schedule a pipeline against it.
• A reconciliation path. You should be able to compute the vendor's headline number yourself from their inputs for at least one date, and have it match.

Run the reconciliation yourself

The cheapest useful diligence on any of these is to compare two of them on one date. If you have IvyDB or a Bloomberg seat, pull the same moment from FlashAlpha and see whether the numbers agree:

curl "https://historical.flashalpha.com/v1/exposure/summary/SPY?at=2019-08-14T14:00:00" \
  -H "X-Api-Key: YOUR_KEY"

The at parameter is ET, so 14:00:00 lands exactly on one of IvyDB's three intraday snapshots, which makes it a clean comparison point. Replay is Alpha tier and served from historical.flashalpha.com; live endpoints are on lab.flashalpha.com, where single-expiry GEX on a single-name equity is the Free-tier call and the full exposure summary needs Growth. The methodology whitepaper documents the dealer-sign convention and its stated limitations, so you can see which assumptions you would be adopting before adopting any.

Deep dives: Bloomberg, LSEG Workspace, OptionMetrics IvyDB, ORATS. Institutional datasheet: /institutional.

Sources

All figures are as of August 2026. Where a vendor does not publish pricing, the figure is marked as reported rather than stated, and your negotiated number will differ.

• NeuGroup, Bloomberg Terminals: How Much More You'll Pay Next Year - the $31,980 single-seat and $28,320 multi-seat annual figures, and the 6.5% increase they follow from.
• Columbia University Libraries, Bloomberg data download limits - the daily, concurrent-field and monthly unique-security limits, and the note that Bloomberg does not publish them.
• Bloomberg, API Library - BLPAPI, B-PIPE and Data License as distinct products.
• LSEG, Eikon withdrawal and transition to Workspace - Eikon was withdrawn at midnight GMT on 30 June 2025.
• Vendr, LSEG / Refinitiv pricing data - the reported per-seat ranges. LSEG does not publish Workspace pricing, so treat these as indicative.
• OptionMetrics, data products - IvyDB US from January 1996, and the full product list including ETF, Futures, Beta, Implied Dividend and the international sets.
• OptionMetrics, IvyDB US Intraday - the 10:00, 14:00 and 15:45 snapshot times and the January 2018 start.
• OptionMetrics, IvyDB Signed Volume - five- and thirty-minute intervals plus an end-of-day file, from January 2016.
• OptionMetrics, about - founded 1999; IvyDB US launched the same year.
• WRDS, OptionMetrics - academic distribution and licence terms.
• ORATS, Data API - published tiers at $99 delayed, $199 live and $399 live-intraday per month.
• ORATS, near end-of-day data - EOD history back to 2007, captured shortly before the close.
• ORATS, one-minute intraday data - one-minute history from August 2020.

These five are not ranked, because they are not comparable on a single axis. Bloomberg and LSEG sell breadth to a person. OptionMetrics sells depth and provenance to a researcher. ORATS sells a packaged backtest. FlashAlpha sells the computed positioning layer to a model. The expensive mistake is buying one to do another's job: a terminal seat cannot underwrite a research pipeline, a research archive cannot underwrite a live strategy, and a computed layer cannot answer a question about 2008. Decide what is stored, who owns the methodology, and whether a person or a model is reading, and the shortlist usually collapses to one obvious answer plus one you already own.